Cessatech A/S
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Analgesic Effect, and Feasibility of Intranasal CT001 in Pediatric Patients (NCT06364072) | Cessatech A/S | 2024-05-27 |
| Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 (NCT05508594) | Cessatech A/S | 2022-09-05 |
| Pharmacokinetic Study of Intranasal CT001 in Children 1-17 Years of Age Undergoing Elective Surgical Procedures (NCT04897750) | Cessatech A/S | 2021-08-19 |
| Study of CT001 in Healthy Volunteers (NCT04807335) | Cessatech A/S | 2021-03-17 |
Track Cessatech A/S automatically
Every clearance here is in the API, with alerts when new ones post.